Allakos Inc (ALLK)

Etorro trading 970x250

About Allakos Inc

Allakos Inc. operates as a clinical stage biopharmaceutical company. The company’s lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; and a Phase II/III study for the treatment of eosinophilic esophagitis. The is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, severe allergic conjunctivitis, chronic urticaria, and indolent systemic mastocytosis. Allakos Inc. was incorporated in 2012 and is headquartered in Redwood City, California. Address: 975 Island Drive, Redwood City, CA, United States, 94065

Allakos Inc News and around…

Latest news about Allakos Inc (ALLK) common stock and company :

Allakos Is a Cautionary Tale of Biopharmaceutical Investing
12 Jan, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips ALLK stock dropped off a cliff following disappointing study results, which illustrates what can go wrong in risky biopharma equities. The post Allakos Is a Cautionary Tale of Biopharmaceutical Investing appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Peek Under The Hood: ESGV Has 13% Upside
11 Jan, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard ESG US.

We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate
09 Jan, 2022 Yahoo! Finance

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Why Allakos Stock Plummeted 87.5% in the Last Month of 2021
06 Jan, 2022 FinancialContent

The biotech stock is now down roughly 93% over the last year.

After a Clinical-Data Bombshell, Allakos Might Actually Be a Buy
05 Jan, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips After a well-publicized clinical-data letdown, it may be time to go long as the worst-case scenario has already been priced into ALLK stock. The post After a Clinical-Data Bombshell, Allakos Might Actually Be a Buy appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Down 86.1% in 4 Weeks, Here's Why Allakos Inc. (ALLK) Looks Ripe for a Turnaround
04 Jan, 2022 Yahoo! Finance

Allakos Inc. (ALLK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Has AbbVie (ABBV) Outpaced Other Medical Stocks This Year?
04 Jan, 2022 Yahoo! Finance

Here is how AbbVie (ABBV) and Allakos Inc. (ALLK) have performed compared to their sector so far this year.

(ALLK) - Analyzing Allakos Inc's Short Interest
28 Dec, 2021 FinancialContent

Allakos Inc's (NASDAQ:ALLK) short percent of float has fallen 26.46% since last its last report. The company recently reported that it ...

54 Biggest Movers From Thursday
27 Dec, 2021 FinancialContent

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products ...

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
26 Dec, 2021 FinancialContent

Biopharma stocks eked out modest gains in the week endingDec. 23, with regulatory decisions, clinical readouts and COVID-19 ...

Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
23 Dec, 2021 FinancialContent

Toward the end of trading Thursday, the Dow traded up 0.77% to 36,030 while the NASDAQ rose 1% to 15,677. The S&P also rose, gaining ...

12 Health Care Stocks Moving In Thursday's Intraday Session
23 Dec, 2021 FinancialContent

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 33.33% to $1.96 during Thursday's regular session. As ...

Dow Eyes Third-Straight Pop Ahead of Christmas Break
23 Dec, 2021 FinancialContent

Stocks continue to distance themselves from the omicron-inspired selloff earlier this week, with all three major benchmarks eyeing a third-straight daily win.

Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet
23 Dec, 2021 FinancialContent

Midway through trading Thursday, the Dow traded up 0.62% to 35,975.34 while the NASDAQ rose 0.66% to 15,624.94. The S&P also rose, ...

38 Stocks Moving In Thursday's Mid-Day Session
23 Dec, 2021 FinancialContent

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with ...

10 Biggest Price Target Changes For Thursday
23 Dec, 2021 FinancialContent

Barclays lifted the price target on Cintas Corporation (NASDAQ: CTAS) from $470 to $500. Cintas shares rose 1.2% to $434.11 in ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
23 Dec, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! Christmas is almost here but were aren't slowing down as we dive into the biggest pre-market stock movers for Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

18 Stocks Moving in Thursday's Pre-Market Session
23 Dec, 2021 FinancialContent

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expanded ...

50 Biggest Movers From Yesterday
23 Dec, 2021 FinancialContent

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. ...

Peninsula biotech sheds 90% of stock value after drug trials flop
22 Dec, 2021 Yahoo! Finance

Allakos has deep pockets, but its market cap now is roughly equal to its $500 million or so in cash, and it has a new 10-year, $69-per-square-foot lease on its books in San Carlos.

Notable Wednesday Option Activity: ALLK, BBIO, CPLG
22 Dec, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Allakos Inc (ALLK), where a total of 24,477 contracts have traded so far, representing approximately 2.4 million underlying shares. That amounts to about 530.9% of ALLK's average daily trading volume over the past month of 461,010 shares..

Mid-Afternoon Market Update: CalAmp Drops After Q3 Results; Red Cat Holdings Shares Surge
22 Dec, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded up 0.51% to 35,674.84 while the NASDAQ rose 0.53% to 15,422.40. The ...

BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today
22 Dec, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There's a new ETF on the block from BAD Investment Company and it seeks to offer investments in sin stocks for interested traders. The post BAD ETF: The Top “Sin Stock” Holdings in the New Anti-ESG Fund That Debuts Today appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

12 Health Care Stocks Moving In Wednesday's Intraday Session
22 Dec, 2021 FinancialContent

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) stock rose 89.77% to $2.81 during Wednesday's regular session. As of 12:30 EST, ...

Why Allakos Shares Are Plummeting Today
22 Dec, 2021 FinancialContent

Allakos Inc (NASDAQ: ALLK) is trading significantly lower Wednesday afterthe company announced ENIGMA 2 and KRYPTOS studies did ...

ALLK Stock Alert: Why Is Allakos Absolutely Plunging Today?
22 Dec, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Allakos' recent study results have sent ALLK stock straight to the bottom. Here's what investors should know right now. The post ALLK Stock Alert: Why Is Allakos Absolutely Plunging Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First...

Stocks Extend Rally as VIX Moves Lower
22 Dec, 2021 FinancialContent

The market rebound is carrying onto Wednesday's trading, with the Dow Jones Industrial Average erasing this morning's losses to eye a 161-point pop. Both the S&P 500 Index and Nasdaq Composite (are not far behind.

Mid-Day Market Update: Nasdaq Rises Over 100 Points; Allakos Shares Plunge
22 Dec, 2021 FinancialContent

Midway through trading Wednesday, the Dow traded up 0.41% to 35,637.05 while the NASDAQ rose 0.80% to 15,463.85. The S&P also rose, ...

32 Stocks Moving In Wednesday's Mid-Day Session
22 Dec, 2021 FinancialContent

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple ...

Expert Ratings For Allakos
22 Dec, 2021 FinancialContent

Allakos (NASDAQ:ALLK) has observed the following analyst ratings within the last quarter: Bullish Somewhat ...

Allakos Inc (ALLK) is a NASDAQ Common Stock listed in , ,

970x250